A Study to Evaluate the Safety and Effectiveness of WF10 Given to Patients With Late-Stage HIV Disease

Completed · Phase 3

Conditions studied: HIV Infections

In brief

The purpose of this study is to see if it is safe and effective to give WF10 to adults with late-stage HIV disease. WF10 is suspected to help the immune system fight infection and slow HIV disease progression.

Key facts

Study ID

NCT00002244

Run by

OXO Chemie

People needed

240

Last updated by the study team

2005-06-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients may be eligible for this study if they:
• Are HIV-positive.
• Have a CD4 cell count of less than 50 cells/mm3 within 14 days prior to study entry.
• Are at least 18 years old.
• Have received anti-HIV drugs at some time in the past.
• Agree to practice abstinence or use effective methods of birth control, including the pill, during the study.

You may not qualify if…

• Patients will not be eligible for this study if they:
• Are being treated for any form of cancer within 30 days of study entry.
• Have ever received an HIV vaccine.
• Have received steroids within 30 days prior to study entry. (Note: Testosterone is allowed.)
• Have received certain medications, including anti-HIV treatments that are not approved by the FDA.
• Have participated in another WF10 study.
• Have an illness or any condition that might exclude them from this study.
• Are pregnant or breast-feeding.
• Abuse drugs or medications.
• Received a blood transfusion within 45 days prior to study entry.

Where it is running

• Univ of Alabama at Birmingham — Birmingham, Alabama, United States
• Tower Infectious Disease Med Ctr — Los Angeles, California, United States
• Highland Gen Hosp / San Francisco Gen Hosp — Oakland, California, United States
• ViRx Inc — San Francisco, California, United States
• UCSF - San Francisco Gen Hosp — San Francisco, California, United States
• George Washington Univ Med Ctr — Washington D.C., District of Columbia, United States
• Univ of Miami School of Medicine — Miami, Florida, United States
• Hillsborough County Health Dept — Tampa, Florida, United States
• Ctr for Quality Care — Tampa, Florida, United States
• AIDS Research Consortium of Atlanta — Atlanta, Georgia, United States
• Leahi Hosp / Univ of Hawaii — Honolulu, Hawaii, United States
• Northwestern Univ Med School — Chicago, Illinois, United States
• Rush Med Ctr / Section of Infectious Diseases — Chicago, Illinois, United States
• The CORE Ctr — Chicago, Illinois, United States
• Univ of Iowa Hosp & Clinic — Iowa City, Iowa, United States
• Boston Med Ctr / Clinical Research Office — Boston, Massachusetts, United States
• Univ Health Ctr — Detroit, Michigan, United States
• Regions Hosp — Saint Paul, Minnesota, United States
• Truman Med Ctr / Infectious Disease Clinic — Kansas City, Missouri, United States
• Newark Community Health Ctr — Newark, New Jersey, United States
• Univ of New Mexico Health Science Center — Albuquerque, New Mexico, United States
• Associates in Med and Mental Health — Tulsa, Oklahoma, United States
• MCP Hahnemann Univ — Philadelphia, Pennsylvania, United States
• Ludwig Lettau Private Practice — Charleston, South Carolina, United States
• Burnside Clinic — Columbia, South Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.